Xconomy National

Archives

by in

Entry	Author	Date	Location
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers	Erin Kutz	12/16/11	Boston
Third Rock Looks to Fight Fat in a New Way, With Ember Therapeutics	Luke Timmerman	12/15/11	Boston
Xconomist of the Week: Larry Smarr’s Quest for ‘Quantified Health’	Bruce V. Bigelow	11/22/11	San Diego
Rhythm Adds Former Merck VP as CEO	Erin Kutz	11/09/11	Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter	Gregory T. Huang	10/28/11	Boston
New Genzyme CEO, Biogen Scores in 2nd MS Pill Trial, Nanotech Drug Startups Nab Funds, & More Boston-Area Life Sciences News	Erin Kutz	10/28/11	Boston
MPM-Backed Rhythm Advances Drug Programs in Diabetes and Obesity	Arlene Weintraub	10/25/11	Boston
Orexigen’s Diet Drug Springs Back to Life, Independa Gets $1.6M, NuVasive Faces Big Judgments in Patent Dispute, & More San Diego Life Sciences News	Bruce V. Bigelow	09/22/11	San Diego
Orexigen Revives Obesity Drug After One More Go-Round With FDA	Luke Timmerman	09/20/11	San Diego
Tensha Nabs $15M, Termeer Gives MIT $10M, Stata Puts $10M Into NABsys, & More Boston-Area Life Sciences News	Erin Kutz	09/16/11	Boston
GI Dynamics Starts Trading on Aussie Exchange, Eyes U.S. Pilot Study for Device in Diabetes and Obesity	Arlene Weintraub	09/14/11	Boston
Pfizer Grows in Cambridge, Repligen Eyes Imaging Approval, GI Dynamics Gets Aussie IPO, & More Boston-Area Life Sciences News	Erin Kutz	09/02/11	Boston
GI Dynamics Raises $85M USD in Aussie IPO	Erin Kutz	08/30/11	Boston
Vivus Adds $45.8M	Luke Timmerman	08/23/11	San Francisco
Amylin & Takeda Halt Obesity Drug Development	Bruce V. Bigelow	08/04/11	San Diego
GI Dynamics and Exa File for IPOs in Weight Loss Devices, Automotive Software	Gregory T. Huang	08/04/11	Boston
Arena Passes Small Study, in Bid to Answer FDA Questions About Obesity Drug	Luke Timmerman	08/02/11	San Diego
Compuware Scoops Up DynaTrace, Medtronic Buys Salient Surgical, Avedro Snaps Up $25M, & More Boston-Area Deals News	Erin Kutz	07/13/11	Boston
Rib-X Inks Sanofi Deal, Zafgen Gets $33M Series C, Allegro Adds $5.4M, & More Boston-Area Life Sciences News	Erin Kutz	07/08/11	Boston
Zafgen Pockets $33M To Take Obesity Drug Through Next Big Step in Clinical Trials	Arlene Weintraub	07/07/11	Boston
A San Diego Sampler from the War on Diabetes	Bruce V. Bigelow	06/24/11	San Diego
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold; Shares Tank	Luke Timmerman	06/03/11	San Diego
Biotech’s Missed Opportunity: Small-Town and Rural America	Luke Timmerman	04/18/11	National
Arena Adds $35.5M	Luke Timmerman	03/29/11	San Diego
Amylin and Takeda Suspend Obesity Study to Consider Metreleptin Data	Bruce V. Bigelow	03/16/11	San Diego
Vivus to Try Again By Year’s End	Luke Timmerman	02/28/11	San Francisco
Orexigen Axes 40 Percent of Workforce After FDA Turns Down Obesity Drug	Luke Timmerman	02/09/11	San Diego
What’s Brewing at Massive Health? A Chat with Newly Funded Co-Founders Sutha Kamal and Aza Raskin	Wade Roush	02/02/11	San Francisco
Orexigen Fails to Win FDA Approval of Obesity Drug, Stock Crashes	Luke Timmerman	02/01/11	San Diego
San Diego’s Fight Against Diabesity: The Photo Gallery	Luke Timmerman	01/28/11	San Diego
Page 1 of 5	next page »